Biomaterial-induced sarcomagenesis is not associated with microsatellite instability by Weber, Achim et al.
ORIGINAL ARTICLE
Biomaterial-induced sarcomagenesis is not associated
with microsatellite instability
Achim Weber & Annette Strehl & Erik Springer &
Torsten Hansen & Arno Schad & C. James Kirkpatrick
Received: 18 June 2008 /Revised: 4 October 2008 /Accepted: 13 November 2008 / Published online: 19 December 2008
# Springer-Verlag 2008
Abstract Sarcomagenesis, in contrast to carcinogenesis, is
poorly understood. Microsatellite instability has been impli-
cated in the development of many cancers, in particular
those associated with chronic inflammatory conditions. In
an experimental animal model, rats developed not only a
peri-implantational chronic inflammatory reaction, but also
malignant mesenchymal tumors in response to different
biomaterials. Therefore, it was the aim of our study to test if
the development of biomaterial-induced sarcomas is charac-
terized by a mutator phenotype. A multiplex-PCR approach
was designed to screen biomaterial-induced sarcomas for the
presence of microsatellite instability. Seven different micro-
satellite loci were tested in ten tumors for microsatellite
instability using a fluorochrome-labelled multiplex-PCR
and subsequent fragment analysis. All tumors provided a
microsatellite-stable phenotype at all loci tested. Our data
suggest that microsatellite instability is rarely or not at
all a feature of malignant transformation of biomaterial-
induced soft tissue tumors. Thus, there is no evidence that a
mutator phenotype is a hallmark of biomaterial-induced
sarcomagenesis.
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Introduction
Tumorigenesis is now widely accepted as resulting from
a stepwise accumulation of genetic instability [1]. The
biological and molecular mechanisms involved in the
development of carcinomas in humans and mammals have
been extensively investigated. In contrast, the molecular
steps in the development of sarcomas and other soft tissue
tumors are less well understood. A progression from a
benign precursor lesion to malignant tumor, characterisitic
of many epithelial tumors, is exceptional for soft tissue
tumors. However, a biological continuum of benign and
malignant soft tissue tumors has been postulated for
example in the case of lipomatous [2] and nerve sheath
tumors [3, 4].
In a previous study, we had established an animal model
for the tumorigenesis of soft tissue tumors [5]. Malignant
mesenchymal tumors were induced around subcutaneously
implanted biomaterial disks. In addition to fully developed
tumors, implantation sites showed lymphocyte and macro-
phage infiltrates reflecting an inflammatory reaction, as a
characteristic response to the implantation of foreign
materials [6, 7] as well as hyper-proliferative lesions,
reflecting precursor lesions. This animal model allowed a
detailed investigation of sarcoma tumorigenesis, especially
because a spectrum of preneoplastic lesions could be
identified.
Several mechanisms are known to result in genetic
instability and consequent malignant transformation of
cells. One pathway is the development of chromosomal
instability with numerical and structural chromosomal
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changes and aneuploidy of tumor cells. Another pathway is
the development of a “mutator phenotype” with changes at
the nucleotide level. These alterations may result in the
accumulation of multiple mutations in genes relevant to cell
growth and homeostasis, eventually leading to growth
advantage and transformation of cells. Multiple short
tandem repetitive DNA-sequences, also known as micro-
satellites, are present throughout the genome of humans and
other mammals [8]. A mutator phenotype is frequently
reflected by widespread sequence length alterations of these
microsatellites, designated as microsatellite instability [9,
10]. Besides inherited deficiencies of mismatch repair
(MMR) genes and inactivation by methylation, an under-
lying impairment of repair enzymes in association with
chronic inflammation [11, 12] has been demonstrated, most
likely due to oxidative stress [13].
While there is a clear association of specific or typical
chromosomal translocations or translocation of gene fusion
products with many soft tissue tumors, microsatellite
instability has also been reported for some entities [14–
17]. Since a chronic inflammatory condition is associated
with microstallite-associated carcinogenesis, we sought to
investigate if the tumorigenesis of biomaterial-induced
sarcomas is based on the development of a mutator pheno-
type. Using the above-mentioned rat model, biomaterial-
induced sarcomas were screened for microsatellite instability.
Materials and methods
Animal model
Ten formalin-fixed, paraffin-embedded tumor samples
(Table 1) were retrieved from the previously published rat
sarcoma collective [5]. Briefly, in this study a total of 490
Fischer rats had been implanted with nine different standard
medical grade biomaterials. In about one quarter of implan-
tations, animals developed (mostly malignant) mesenchymal
tumors of different histological type, including fibrosarcomas,
leimyosarcomas, and rhabdomyosarcomas, around the
implantation sites.
Laser capture microdissection
Sections of normal and transformed tissues (either tumors
or precursor lesions) from the above mentioned paraffin
blocks were prepared on membrane mounted-slides
(PALM MembraneSlides, P.A.L.M., Bernried, Germany)
and de-paraffinized. Microdissection was performed using a
PALM MicroBeam system with a pulsed UV-A nitrogen
laser (337 nm). The selected areas were marked, cut out,
and pulsed into a 0.5-ml microfuge tube with adhesive
filling (PALM AdhesiveCaps, P.A.L.M.), taking care to
keep the normal and tumor tissues separate. “Normal
tissue” was prepared so distant from the implantation site
that it was morphologically not affected by the implants and
corresponding tissue reactions.
Multiplex PCR and fragment analysis
Since (in contrast to human and mouse) no well-established
and characterized panels of markers for the analysis of
microsatellite instability was described in rat, sequence
information of rat microsatellite loci was taken from several
studies [18–20]. In order to compensate for a potentially
low sensitivity of these markers in detecting MSI, seven
markers instead of the more common panel of five markers
was used (Table 2). DNA was isolated by proteinase K
digestion, followed by phenol-chloroform extraction and
ethanol/salt precipitation using standard protocols [21].
Two multiplex PCR-reactions were performed using
two different primer mixtures with fluorochrome-labelled
oligonucleotide primers. In each case, either the forward or
the reverse primer was fluorochrome-labelled. Primermix A
contained oligonucleotide primers of the loci GH, NGFR,
SECR, and UCP; primermix B contained oligonucleotide
primers of the loci ANF, PPY, and SMST (Table 2). Non-
fluorescent oligonucleotide primers were purchased from
Table 1 Biomaterial-induced
soft tissue tumors
The study included a total of
ten different biomaterial-
induced soft tissue tumors.
Every rat was given an identi-
fication code describing the
implanted material. The result-
ing tumor was histologically
diagnosed
Code Implanted biomaterial Tumor
46 PU 101 Aliphatic polyurethane Pleomorphic rhabdomyosarcoma
11 PMMA 84 Polymethylmethacrylate Osteosarcoma
1 PMMA 86 Polymethylmethacrylate Sarcoma, NOS
16 Si 80 Silicone Pre-neoplastic lesion
2 Si 90 Silicone Sarcoma, NOS
4 PVC 105 Polyvinyl chloride Fibrosarcoma
5 NiCr 107 Nickel chromium Dedifferentiated liposarcoma
25 NiCr 107 Nickel chromium Pleomorphic sarcoma
24 Alu 103 Aluminum Spindle cell sarcoma
1 Si 87 Silicone Sarcoma, NOS
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biomers.net, Ulm, Germany and the fluorescent oligonu-
cleotide primers from Sigma-Aldrich, Germany.
The final 25-μl multiplex reaction mix consisted of the
following: 12.5 μl Qiagen-Multiplex-Mastermix (Qiagen,
Hilden, Germany), 2.5 μl 10× primer-mix, 7.5 μl H2O, and
2.5 μl template. The 10× primer-mix was composed by
mixing 50 μM fluorescent primers and 100 μM non-
fluorescent primers at a concentration of 2 μM each in H2O.
PCR was performed using a GeneAmp 9700 thermocycler
(Applied Biosystems, Foster City, CA, USA) under the
following conditions: initial denaturation at 95° for 15 min,
followed by 45 cycles of: 30 s at 94°, 90 s at 54°, and 1 min at
72° with a final 30-min extension period at 60°. The resulting
PCR-product was then analyzed by gel-electrophoresis on a
2% agarose gel and subsequent fragment analysis of the
fluorescently labelled PCR products was performed using a
Beckman Coulter CEQ 8000 Sequencer (Beckman Coulter,
Krefeld, Germany) with the corresponding CEQ System
software. The detected fragments of normal and malignant
tissue were compared to determine the stability for each locus.
Results
Tissue selection and isolation of tumor and normal DNA
Histology of the samples was re-evaluated in order to
define suitable areas of tumor and non-neoplastic tissue,
respectively. In all cases studied, a clear identification of
tumors and non-tumorous areas was possible, providing the
basis for the laser-capture analysis and tissue preparation
(Fig. 1). Following laser-capture (P.A.L.M.)-based tissue
preparation and standard nucleic acid extraction, a suffi-
cient amount and quality of DNA could be isolated from all
samples analyzed.
Development of a multiplex-PCR assay for microsatellite
instability testing
PCR conditions were first optimized, and all samples were
initially tested in a single PCR setting. In the case of the
GH and PPY locus, respectively, significantly lower
amplification sizes were observed when compared to
information from either the gene bank (see Table 2) and/
or the literature [18]. In the case of the PPY locus, higher
amplification sizes were observed. The SECR locus
revealed rather a single peak instead of the characteristic
stuttering pattern in all samples tested. However, all loci
displayed a constant size comparing different animals (due
to the same genetic background of animals).
After successfully testing each pair of oligonucleotide
primers in a single-PCR, a multiplex-PCR-assay was
designed by dividing the seven different primers into two
groups of three or four primer pairs, respectively. Using this
multiplex-PCR approach, all loci test were successfully
amplified and analyzed by fluorescence-based fragment
analysis. No difference between single PCR fragment
analysis patterns and the multiplex approach was observed,
Table 2 Microsatellite loci and oligonuceotide primer sets
Locus Acc. No. Oligo nucleotide sequence Sizea Dye Ref.
Mix A
GH X12967 F 5′-ATGGGAGGGAACAAGTCTTC-3′ 135 D4 [18, 19]
R 5′-GAGGGAGAGAGAAAGAGAGACAG-3′
NGFR X05137 F 5′-ACCCCACAATCCAACACTATAC-3′ 126 D3 [18, 19]
R 5′-GCAGGATCTAGTCTCAGCCC-3′
SECR M64033 F 5′-ACCATGGAGCCTCTACTGC-3′ 194 D4 [18, 20]
R 5′-GTCCCGTCCGAGTGTCTT-3′
UCP X12925 F 5′-TGCCCGTCTCTGTTACTCAT-3′ 111 D4 [18, 19]
R 5′-CAAGAACCCTGAGGCAATAA-3′
Mix B
SMST K02248 F 5′-TTTCCAGGTGCCAAATGTAG-3′ 154 D4 [18, 20]
R 5′-TATATTGTGACAAAAGAAAGGCAC-3′
ANF K02062 F 5′-TCCACAACCTTGATCTTTCG-3′ 160 D2 [18, 20]
R 5′-GTTGAGGGCCATAGTGTGAC-3′
PPY M27450 F 5′-CACACTGACCAGGCCTAGG-3′ 153 D3 [18, 20]
R 5′-TGTCAGCTCAGCTGCTTTG-3′
Microsatellite loci and oligonucletide primer sequences information
GH growth hormone, NGFR nerve growth factor receptor, SECR secretin, UCP uncoupling protein, SMST somatostatin, ANF atrial natriuretic
factor, PPY pancreatic polypeptide
a Sizes are indicated as expected according to NCBI database information and differed significantly from the fragment sizes observed in this study
in case of the GH, UCP, and PPY loci, respectively
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indicating that the multiplex assay used was a valid method
for the simultaneous testing of several microsatellite loci
(Fig. 2).
All microsatellite loci showed a stable phenotype
A total of 140 microsatellites was analyzed, with 70
microsatellites displaying microsatellites of neoplastic or
preneoplastic tissue, and the other 70 reflecting the corre-
sponding normal tissue, respectively. Nearly all micro-
satellites were informative with the exception of three cases
(PND locus of animals: one PMMA 86, two Si90, and four
PVC 105). In these cases, the fragment analysis revealed
signals which were too low or unspecific to be readable, so
that a definite statement about the stability of the micro-
satellite loci for these particular samples could not be made.
For all other microsatellite loci tested, no size or frame
shifts were observed on comparing normal and the tumor/
precursor lesion tissue (see examples in Fig. 3). Thus, even
assuming that the PND locus in case of the three tumors, in
which this particular locus was not amplified, had shown a
change in microstatellite pattern, the overall diagnostic
criteria for microsatellite instability would not have been
fulfilled. Therefore, all loci provided stable microsatellites.
Fig. 1 Examples of a biomaterial-induced sarcoma (pleomorphic
rhabdomyosarcoma from animal 46 PU 101). a Histology revealed a
pleomorphic tumor with rhabdomyoblastic differentiation (upper left)
and a rather well-defined border surrounded by a fibrous connective
tissue capsule with proliferative lesions, possibly pre-neoplastic.
(Tissue for DNA isolation was prepared by laser-microdissection
from tumors, capsule tissue, and surrounding non-neoplastic tissue,
respectively). b Higher magnification of the tumor shows atypical
tumor cells with vacuoles similar to lipoblasts and a mitotic figure
(arrow). c Tumor cells show a widespread positive cytoplasmic
immunoreactivity for desmin, d as well as a strong nuclear positivity
for myogenin
198 Virchows Arch (2009) 454:195–201
Discussion
The etiology of most benign and malignant soft tissue
tumors is unknown. The vast majority of soft tissue tumors
seem to arise without an apparent causative factor. Among
suspected or proven causative factors are genetic and
environmental factors, viral infections, immune deficien-
cies, local environmental factors like scars or implants as
well as chronic inflammatory conditions. In contrast to
many epithelial tumors, a clear multistage tumorigenesis or
a clear precursor-sarcoma-sequence so far has rarely been
identified in soft tissue tumors. However, the demonstration
of common genetic alterations in the case of benign and
malignant lipomatous tumors [2, 22] as well as benign and
malignant nerve sheath tumors [3, 4] makes it reasonable
that a stepwise development in soft tissues tumors is
relevant for at least some entities.
In a previous study, an experimental animal model has
been presented in which a high incidence of malignant soft
tissue tumors arose around implanted biomaterials [5].
Sarcoma induction by biomaterials required direct contact
with the respective substances. Remarkably, a broad
spectrum of soft tissue tumors developed, obviously
independent of the specific kind of agent implanted and
lacking any consistent correlation between biomaterial
groups and specific histological type of tumor. This
observation suggested that it is not a specific genetic
damage, interfering with a defined pathway, which is
Fig. 2 Comparison of micro-
satellite profiles in single versus
multiplex amplification show no
changes in microsatellite pat-
terns. In each pair, the micro-
satellite pattern from the single
PCR amplification is shown in
the upper row and the profile of
the multiplex amplification is
shown in the lower row. (In case
of NGRF and PPY, respectively,
only one locus is shown while
the fluorochromes of further loci
are not displayed). Amplificates
result from tumor DNA of ani-
mal 5 NiCr 107 showing loci
UCP and GH and NGFR loci
(primer mix A) and locus PPY
(primer mix B)
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induced. In this case, one would expect a less heterogenous
spectrum of histologic entities, as are described for several
specific carcinogenic substances resulting in defined tumor
entities, e.g. mesotheliomas following asbestos exposure
[23]. The heterogenous spectrum of lesions observed in this
study rather argues for a (or several) more or less random
insult(s). What might be the nature of this insult?
A characteristic hallmark of tumors developing in this
model was the reaction of the peri-tumorous tissue,
characterized by a chronic inflammation and hyperpro-
liferative changes at peri-implantational sites, known as a
typical response to foreign materials for a long time [6].
Chronic inflammation, characterized by free radical stress,
can be a significant contributor to carcinogenesis [13, 24].
One could easily imagine that the microenvironment
around the implants, probably through inflammation-
mediated factors, might interfere with replication repair
enzymes in this proliferation. Such a defect is expected to
be reflected by microsatellite instability. There are several
observations providing evidence that chronic inflammation
indeed can result in an impaired mismatch-repair capacity,
even in the absence of any genetic inactivation of the
mismatch repair system [11–13]. Although rare, micro-
satellite instability has been observed in sarcomas of
different histogenetic type [14, 16]. This prompted us to
search for microsatellite instability in biomaterial-induced
sarcomas. However, in the present study we have not
observed a single microsatellite instability, neither in fully
developed tumors nor in preneoplastic lesions. Based on
this observation, we found no evidence that a replication-
repair-associated defect is crucial for biomaterial-induced
sarcomagenesis.
If this is not the case, what could be the responsible
factor? As stated above, with respect to the heterogenous
spectrum of tumor entities, it seems unlikely that a specific
genetic insult underlies biomaterial-induced sarcomagenesis.
Although the diversity of different physical compounds able
to induce soft tissue tumors argues against a direct toxic
effect of substances released, there is obviously the possi-
bility of a genotoxic effect with subsequent genetic or
epigenetic changes. Alternatively, sarcomagenesis is proba-
bly associated with genetic instabilty on the chromosomal
(cytogenetic) level, for example induced by interference with
cell check points. Carcinogen-induced sarcomagenesis in
Trp53+/− mice suggests that loss of p53 function is, at least
in part, an important mechanism in the development of
Fig. 3 No difference in microsatellite profiles comparing tumor and
normal tissue in all tumor and all seven loci tested. In each pair, the
microsatellite pattern from the normal tissue (N) is shown in the upper
row and the pattern of the tumor (T) is shown in the lower row. Loci
UCP, GH, NGFR, SECR, and PPY are shown from animal 11 PMMA
84, loci SMST, and ANF from animal 25 NiCr 107
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sarcomas at the implantation site [24, 25]. Since the
hypothesis that a mutator phenotype could be responsible
for the development of biomaterial-induced sarcomas is not
supported by our data, further investigation should test the
latter possibilities.
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